FREDUN PHARMACEUTICALS L (FREDUN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1987, Fredun PharmaceuticalsLtd manufactures & exports healthcare and pharmaceuticals products[1]

FREDUNUpdated 18 Aug 2026, 16:47

Fredun Pharmaceuticals L

Market Cap

₹2,386Cr.

Current Price

₹1,443

High / Low

₹1,600/344

Stock P/E

53.7

Book Value₹170
Dividend Yield0.02%
ROCE21.5%
ROE15.8%
Face Value₹10.0

About

Incorporated in 1987, Fredun PharmaceuticalsLtd manufactures & exports healthcare and pharmaceuticals products[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jul 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days75981319467126112148466814253
Inventory Days1021406817024922724296264246267219
Days Payable1672212243602052082151011048816171
Cash Conversion Cycle1117-24-96110145139144205225248201
Working Capital Days-54-44-3942666511612697927679
ROCE %14%25%18%16%21%10%10%13%18%17%19%21%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 August 2026 at 16:47


Designed & Shipped by Harshit Bansal